A Phase 2 interventional study of DWP708 in Rash Acneiform, sponsored by Daewoong Pharmaceutical Co. LTD.. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2024-04-04.
Sponsored by Daewoong Pharmaceutical Co. LTD. · Phase 2, Interventional, and Treatment
A Multi-center, Randomized, Double-blind, Placebo-controlled, Therapeutic Exploratory, Phase II Clinical Trial for the Efficacy Investigation and Safety Evaluation of DWP708 for Treating Rash Acneiform
All the patients had Grade ≥2 ERSEs according to the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI-CTCAE) v. 5.0
Daewoong Pharmaceutical Co. LTD. is the lead sponsor of 196 studies on the registry; 33 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients with a history of topical medication
EGF Cream Placebo evenly apply to skin lesion every 12 hr/day
Biological: DWP708
EGF Cream 10 ug/g evenly apply to skin lesion every 12 hr/day
Biological: DWP708
EGF Cream 20 ug/g evenly apply to skin lesion every 12 hr/day
Biological: DWP708
EGF Cream 40 ug/g evenly apply to skin lesion every 12 hr/day
Biological: DWP708
Placebo Comparator: Placebo of DWP708 / BID / up to 28 days Experimental: DWP708 10 ug/g / BID / up to 28 days Experimental: DWP708 20 ug/g / BID / up to 28 days Experimental: DWP708 40 ug/g / BID / up to 28 days
Also known as: EGF cream
To estimate the response rate of Rash acneiform
The effectiveness of the DWP708 was defined as follows: 1. Downgraded to more than 2 steps 2. Downgraded to ≤Grade 1
Time frame: Up to 28 days
To evaluate the patients' Quality of Life (QoL) by Skin evaluation method
SKINDEX-16
Time frame: Up to 56 days
To estimate the amount of change papule and/or pustule
Region of interest (10 \* 10 cm)
Time frame: Up to 56 days
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Acneiform Eruptions
Daewoong Pharmaceutical Co. LTD.